- Home
- PMAX vs ADIL Comparison
PMAX vs ADIL Comparison
Compare PMAX & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PMAX | ADIL |
|---|---|---|
| Founded | 2019 | 2010 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4M | 6.4M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | PMAX | ADIL |
|---|---|---|
| Price | $2.04 | $2.30 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $37.50 |
| AVG Volume (30 Days) | 15.0K | ★ 264.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 24.44 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.23 | $0.13 |
| 52 Week High | $5.20 | $3.67 |
Technical Indicators
Market Signals| Indicator | PMAX | ADIL |
|---|---|---|
| Relative Strength Index (RSI) | 36.26 | 61.66 |
| Support Level | $1.61 | $0.31 |
| Resistance Level | $2.67 | $3.67 |
| Average True Range (ATR) | 0.16 | 0.31 |
| MACD | -0.05 | -0.09 |
| Stochastic Oscillator | 0.15 | 8.71 |
Price Performance
Historical ComparisonAbout PMAX Powell Max Limited
Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. All operations are carried in Hong Kong.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.